Last updated: 2026-09-04 23:15:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Solventum Corporation (SOLV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $91.73, with a market capitalization of $15.64B and a P/E ratio of 10.97. Over the past 52 weeks, its price has ranged from $62.38 to $94.16. This page covers its latest market performance, valuation, price trends and company information.
$15.64B | |
$91.40 | |
$94.16 | |
$47.16 | |
$92.44 | |
394.96K | |
-- | |
10.97 | |
$94.16 | |
$62.38 | |
-- | |
-- |
Solventum Corporation (SOLV) is trading at $91.75 in after-hours trading as of 2026-09-04 22:30:00, down 0.75% ($0.69) from the regular-session close of $92.44.
After-hours trading shows how investors are pricing SOLV after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Solventum Corporation (SOLV) moved from $90.33 to $91.73, representing a gain of 1.55% ($1.40).
The stock traded between $90.65 and $92.08 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 798.89 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 92.4%
SOLV is currently trading at $91.73, placing it 92.4% of the way from its 52-week low of $62.38 to its 52-week high of $94.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 20000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Solventum Corporation (SOLV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.